![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Shingrix for Shingles
FDA Approves Shingrix for Shingles
![ApprovedGreen.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/ApprovedGreen.gif?t=1576044289&width=430)
The FDA approved GlaxoSmithKline’s Shingrix vaccine for treatment of shingles in adults 50 and over.
An FDA advisory committee endorsed Shingrix in September.
Shingrix is a non-live, recombinant subunit vaccine for shingles and its complications, such as postherpetic neuralgia.
Merck’s Zostavax is the only other FDA-approved shingles vaccine.
Upcoming Events
-
21Oct